Leadership Overview
Bharat Biotech has 4 executives leading key functions including financial strategy, revenue operations, business development, and quality assurance.
Committed to global health equity, Bharat Biotech advances medical science through the development of innovative vaccines and bio-therapeutics. This organization maintains a rigorous focus on manufacturing excellence to improve public health outcomes worldwide.
Committed to global health equity, Bharat Biotech advances medical science through the development of innovative vaccines and bio-therapeutics. This organization maintains a rigorous focus on manufacturing excellence to improve public health outcomes worldwide.
Leadership Roles at Bharat Biotech
Srinivas Tadepally - Chief Financial Officer
Srinivas Tadepally, the Chief Financial Officer at Bharat Biotech, directs all fiscal planning and capital allocation strategies. Tadepally manages the financial health of the organization while overseeing complex budgetary requirements for large-scale vaccine manufacturing. By optimizing resource distribution, the Chief Financial Officer ensures the company maintains the necessary liquidity to fund ongoing research and development initiatives. Srinivas Tadepally also coordinates with the board to provide transparent reporting on international market performance and operational expenditures. This leadership role involves mitigating financial risks associated with global supply chain fluctuations and regulatory compliance costs. Through precise fiscal oversight, the Chief Financial Officer supports the long-term sustainability of the company's bio-therapeutic portfolio. By aligning capital investments with strategic growth objectives, Tadepally secures the financial foundation required for the company to continue delivering critical medical solutions across diverse international markets.
Mihir Chhaya - President, Revenue Operations & Strategy
Mihir Chhaya, the President, Revenue Operations & Strategy at Bharat Biotech, architects the commercial frameworks that drive global market penetration. Chhaya oversees the integration of sales data and strategic planning to maximize the reach of the company's vaccine portfolio. By analyzing market trends, the President, Revenue Operations & Strategy identifies emerging opportunities for expansion within the biotechnology sector. Mihir Chhaya also collaborates with cross-functional teams to streamline revenue cycles and improve the efficiency of distribution networks. This leadership role requires constant evaluation of competitive landscapes to maintain the company's market position. Through the implementation of data-driven sales strategies, the President, Revenue Operations & Strategy ensures consistent growth across regional territories. Chhaya focuses on scaling commercial operations to meet the increasing demand for bio-therapeutics, ultimately strengthening the company's influence in the global healthcare industry while maintaining high standards of operational performance.
Mahabubi Shadick - President, Quality
Mahabubi Shadick, the President, Quality at Bharat Biotech, enforces the rigorous standards required for vaccine manufacturing and bio-therapeutic production. Shadick oversees the implementation of global quality management systems to ensure compliance with international health regulations. By directing internal audits and quality control protocols, the President, Quality maintains the integrity of every product manufactured by the company. Mahabubi Shadick also leads the continuous improvement initiatives that optimize production processes and minimize operational risks. This leadership role involves constant collaboration with regulatory bodies to verify that all manufacturing facilities meet stringent safety benchmarks. Through the oversight of quality assurance teams, the President, Quality guarantees that the company delivers safe and effective medical solutions to patients worldwide. Shadick focuses on embedding a culture of excellence across all manufacturing sites, ensuring that the company's commitment to public health remains supported by the highest levels of scientific and operational precision.
Sai Prasad - Business Development Head
Sai Prasad, the Business Development Head at Bharat Biotech, manages strategic partnerships and external collaborations that fuel innovation. Prasad identifies and secures alliances with research institutions and global health organizations to accelerate the development of new vaccines. By fostering these relationships, the Business Development Head expands the company's reach into new therapeutic areas and geographic markets. Sai Prasad also negotiates licensing agreements and joint ventures that enhance the company's intellectual property portfolio. This leadership role involves navigating complex regulatory environments to ensure successful product launches and market entry. Through proactive engagement with industry stakeholders, the Business Development Head drives the company's mission to address unmet medical needs. Prasad coordinates with internal R&D teams to align external opportunities with the company's core manufacturing capabilities. By building a robust network of partners, the Business Development Head ensures the company remains at the forefront of biotechnology advancements.
Explore Leadership Teams in Chemicals & Related Products
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines chemicals to deliver solutions to customers in the global transportation, industrial and consumer markets. The company is located in Wickliffe, Ohio.
Company Leadership



Founded in 1918, Celanese is a chemical and specialty materials company that engineers and manufactures high performance engineered polymers. The company operate through engineered materials, acetate tow, and acetyl chain segments. The company is headquartered in Irving, Texas.
Company Leadership
ES

GH
Founded in 1984, Par Pacific Holdings owns, manages and maintains interests in energy, related retailing and infrastructure businesses. Par Pacific's business is organized into three primary segments of refining, retail and logistics. Par Pacific has refining and logistics assets in Hawaii and Wyoming and a retail distribution network in Hawaii, Idaho and Washington. Par Pacific also owns an equity investment in Laramie Energy, LLC, a joint venture entity focused on producing natural gas in Garfield, Mesa and Rio Blanco Counties, Colorado. The company is headquartered in Houston, Texas.
Company Leadership WM
SR
SF

Founded in 1989, Greenfield Global operates as a producer and supplier of raw materials, ingredients, and additives. They are located in Ontario, Canada.
Company Leadership RS
JJ
MW
AA